NDC codes

405223 NDC codes with hospital pricing data in the network.

• NDC 49702-0264-23 — CABOTEGRAVIR 600 MG/3 ML (200 MG/ML) IM SPER (71 hospitals, 3,008–3,080 samples)
• NDC 264780000 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION FOR EXTRACORPOREAL PRIME (PRE-DIALYSIS ONLY) (128 hospitals, 2,729–3,080 samples)
• NDC 00409765062 — heparin 25,000 unit/NaCl 0.45% 250 mL PREMIX (170 hospitals, 422–3,077 samples)
• NDC 83634050041 — MAGNESIUM SULFATE 2 GM/50ML IV SOLN (82 hospitals, 1,565–3,077 samples)
• NDC 44567042100 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (65 hospitals, 1,516–3,073 samples)
• NDC 00338002302 — DEXTROSE 10 % IN WATER (D10W) INTRAVENOUS SOLUTION (208 hospitals, 2,143–3,070 samples)
• NDC 00409-1463-01 — NALBUPHINE 10 MG/ML INJECTION SOLUTION (205 hospitals, 2,978–3,068 samples)
• NDC 00990795303 — Lactated Ringers: 24 Pouch In 1 Case (0990-7953-03) / 1 Bag In 1 Pouch / 500 Ml In 1 Bag (109 hospitals, 2,672–3,068 samples)
• NDC 70121165701 — PremierPro Rx Triamcinolone Acetonide (144 hospitals, 1,798–3,067 samples)
• NDC 63323041202 — MIDAZOLAM 5 MG/ML INJECTION SOLUTION (184 hospitals, 1,429–3,067 samples)
• NDC 16729-0276-38 — FLUOROURACIL 50 MG/ML INTRAVENOUS SOLUTION (WRAPPER) (116 hospitals, 2,775–3,063 samples)
• NDC 68516-5214-01 — ALBUTEIN 5 % INTRAVENOUS SOLUTION (89 hospitals, 3,016–3,061 samples)
• NDC 72266-0123-01 — ONDANSETRON HCL (PF) 4 MG/2 ML INJ SOLN (17 hospitals, 2,350–3,061 samples)
• NDC 16714-0690-10 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (21 hospitals, 2,646–3,060 samples)
• NDC 00591-2136-68 — PROPOFOL SF 1GM/100ML INJ (9 hospitals, 2,646–3,060 samples)
• NDC 00641-6196-10 — propofol for continuous IV Set (19 hospitals, 2,646–3,060 samples)
• NDC 72572-0612-10 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (19 hospitals, 2,646–3,060 samples)
• NDC 80830-2365-07 — PROPOFOL SF 1GM/100ML INJ (13 hospitals, 2,646–3,060 samples)
• NDC 10019-0033-39 — FENTANYL PER 0.1 MG (6 hospitals, 2,123–3,059 samples)
• NDC 00409255201 — HYDROMORPHONE 1 MG/ML INJECTION SOLUTION (122 hospitals, 921–3,054 samples)
• NDC 72572-0805-01 — VANCOMYCIN 10 GRAM INTRAVENOUS SOLUTION (48 hospitals, 2,827–3,052 samples)
• NDC 72266-0123-25 — ONDANSETRON HCL (PF) 4 MG/2 ML INJECTION SOLUTION (21 hospitals, 2,349–3,051 samples)
• NDC 00409673013 — MAG SULF IN 2GM/50ML (93 hospitals, 1,485–3,051 samples)
• NDC 63323054313 — Heparin Sodium (149 hospitals, 1,007–3,050 samples)
• NDC 00264762320 — Dextrose 10% NaCl 0.2% 250 mL IV Soln (70 hospitals, 2,141–3,050 samples)
• NDC 70121-1720-09 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (19 hospitals, 2,981–3,044 samples)
• NDC 57894050301 — DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN (408 hospitals, 2,206–3,043 samples)
• NDC 00186-1034-01 — UNCLASSIFIED DRUGS (15 hospitals, 2,376–3,042 samples)
• NDC 00409014710 — LIDOCAINE 20 MG/ML (2 %)-EPINEPHRINE 1:100,000 INJECTION SOLUTION (110 hospitals, 1,449–3,042 samples)
• NDC 00409-1464-01 — NALBUPHINE HCL 10 MG/ML IJ SOLN (63 hospitals, 2,975–3,038 samples)
• NDC 00009307301 — METHYLPREDNISOLONE ACETATE 40 MG/ML SUSPENSION FOR INJECTION (296 hospitals, 562–3,037 samples)
• NDC 63323041113 — Midazolam HCl Inj 10 MG/10ML (Base Equivalent) (37 hospitals, 1,426–3,037 samples)
• NDC 00143-9140-25 — CEFAZOLIN SODIUM 3 G IV SOLR (90 hospitals, 2,432–3,035 samples)
• NDC 00143-9331-10 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (50 hospitals, 2,590–3,031 samples)
• NDC 68094-0503-61 — IBUPROFEN 100 MG/5 ML ORAL SUSPENSION (27 hospitals, 2,985–3,030 samples)
• NDC 50242-0041-64 — alteplase 2mg vial (Cathflo) (G/K) (397 hospitals, 805–3,028 samples)
• NDC 25021065502 — Midazolam (102 hospitals, 1,425–3,027 samples)
• NDC 00904-7306-61 — CARVEDILOL 6.25 MG ORAL TAB (99 hospitals, 2,784–3,027 samples)
• NDC 76045000210 — Midazolam: 24 Blister Pack In 1 Carton (76045-002-10) / 1 Syringe, Glass In 1 Blister Pack (76045-002-00) / 1 Ml In 1 Syringe, Glass (78 hospitals, 1,487–3,026 samples)
• NDC 67457-0441-20 — ONDANSETRON 2 MG/ML EXTEMP INJECTION (20 hospitals, 3,016–3,025 samples)
• NDC 00409336510 — HYDROMORPHONE HCL 2 MG/ML IJ SOLN (191 hospitals, 918–3,024 samples)
• NDC 25021061282 — MAGNESIUM SULFATE 4 GM/100ML IV SOLN (52 hospitals, 1,511–3,023 samples)
• NDC 60687028265 — azithromycin 250 mg Tab (71 hospitals, 1,780–3,022 samples)
• NDC 69374091910 — succinylcholine 200 mg/10 mL Soln-IV 10 mL SDV (176 hospitals, 1,213–3,022 samples)
• NDC 44567070725 — Cefazolin Sodium For Inj 1 GM (262 hospitals, 1,049–3,020 samples)
• NDC 55513-0710-01 — DENOSUMAB 60 MG/ML SUBCUTANEOUS SYRINGE (281 hospitals, 1,713–3,018 samples)
• NDC 76045000900 — HYDROMORPHONE (PF) 1 MG/ML INJECTION SYRINGE (69 hospitals, 1,029–3,018 samples)
• NDC 25021-0701-02 — KETOROLAC 60 MG/2 ML INTRAMUSCULAR SOLUTION|DISCARDED DRUG NOT ADMINISTERED (20 hospitals, 1,746–3,015 samples)
• NDC 63323-0285-64 — ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION (67 hospitals, 2,555–3,014 samples)
• NDC 36000032201 — Labetalol HCl IV Soln 5 MG/ML (131 hospitals, 861–3,012 samples)